A Case of Hidden Neuroborreliosis
Tracey N Webb1, Daniel Kaufman1, Monika Mikolajczak3, Boris Kobilja3, Timothy Bauer3, Hector Ojeda-Martinez2, Yakov Isakov3
1Neurology, 2Infectious Disease, Northwell Health, 3Northwell Health
Objective:

To present a diagnostically challenging case of neuroborreliosis with a markedly elevated Lyme Index Value (LIV) but negative confirmatory Western blot. The case illustrates the diagnostic difficulty of neuroborreliosis in the absence of classic peripheral symptoms or known tick exposure.

Background:

A middle-aged female presented to the emergency department three times with two weeks of progressive neurological symptoms, including lower back pain, a diffuse burning sensation, right lower extremity weakness, and right-sided paresthesia. She also reported a three-month history of increased fatigue but denied recent illness or known tick exposure.

Initial labs revealed elevated liver enzymes—presumed secondary to acetaminophen overuse for pain—and neutrophilic leukocytosis. Lyme IgM and IgG serologies were positive; however, the Western blot confirmatory test was negative. Notably, the patient had a remote history of Lyme disease and Ehrlichiosis, treated 20 and 10 years ago, respectively.

MRIs of the brain and cervical spine were unrevealing. MRI of the thoracic spine revealed moderate enhancement of the cauda equina, suggesting arachnoiditis, without cord abnormalities. A lumbar puncture demonstrated a lymphocytic pleocytosis (WBC 359) and elevated protein (118 mg/dL), consistent with arachnoiditis. She then completed a 5-day course of high-dose IV corticosteroids.

Subsequently, CSF Lyme Index Value (LIV) returned severely elevated (17; normal <0.7), confirming neuroborreliosis. The patient later developed new symptoms, including vertigo, tinnitus, and headaches, and was treated with IV ceftriaxone and started on gabapentin for symptomatic relief. She remains under close outpatient follow-up.

Design/Methods:
N/A
Results:

N/A

Conclusions:
This case highlights the complexity of diagnosing neuroborreliosis, particularly in patients lacking classical features. The markedly elevated CSF LIV was instrumental in confirming the diagnosis in this patient, despite a negative Western blot. Clinicians should maintain a high clinical index of suspicion for neuroborreliosis in patients with subacute neurological symptoms and atypical presentations, especially when standard serological testing is inconclusive.
10.1212/WNL.0000000000217354
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.